6-oxo.-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases

Details for Australian Patent Application No. 2007332861 (hide)

Owner Novartis AG

Inventors Zawel, Leigh; Straub, Christopher Sean; Wang, Run-Ming David; Chen, Zhuoliang; Chen, Ming

Agent Davies Collison Cave

Pub. Number AU-A-2007332861

PCT Pub. Number WO2008/073305

Priority 60/873,436 07.12.06 US

Filing date 7 December 2007

Wipo publication date 19 June 2008

International Classifications

C07D 233/96 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 241/18 (1970.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 403/10 (1970.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/073305 Priority application(s): WO2008/073305

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007332862-Organic compounds

2007332859-Method and system for low speed control of a video surveillance system motor